Endovia is pursuing FDA veterinary approval for its cannabinoid drug targeting canine cancer and chronic pain in the companion-animal market.
Why a cannabis business is betting on dogs to reach FDA approval is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Why a cannabis business is betting on dogs to reach FDA approval
Comments are closed, but trackbacks and pingbacks are open.